Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers

[1] Lecendreux M(2011)Prevalence of attention deficit hyperactivity disorder and associated features among children in France J Atten Disord 15 516-524

[2] Konofal E(2010)Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children–United States, 2003 and 2007 MMWR Morb Mortal Wkly Rep 59 1439-1443

[3] Faraone SV(2008)How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample: results of the BELLA study Eur Child Adolesc Psychiatry 17 59-70

[4] Döpfner M(2007)Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children Arch Pediatr Adolesc Med 161 857-864

[5] Breuer D(2007)Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Br J Psychiatry 190 402-409

[6] Wille N(2006)The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 163 716-723

[7] Erhart M(2009)Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis Br J Psychiatry 194 204-211

[8] Ravens-Sieberer U(2001)Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Child Adolesc Psychiatry 40 1352-1355

[9] Froehlich TE(2011)ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents Pediatrics 128 1007-1022

[10] Lanphear BP(2011)Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence Eur Child Adolesc Psychiatry 20 S235-S242

[1] Lecendreux M(2011)Prevalence of attention deficit hyperactivity disorder and associated features among children in France J Atten Disord 15 516-524

[2] Konofal E(2010)Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children–United States, 2003 and 2007 MMWR Morb Mortal Wkly Rep 59 1439-1443

[3] Faraone SV(2008)How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample: results of the BELLA study Eur Child Adolesc Psychiatry 17 59-70

[4] Döpfner M(2007)Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children Arch Pediatr Adolesc Med 161 857-864

[5] Breuer D(2007)Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Br J Psychiatry 190 402-409

[6] Wille N(2006)The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 163 716-723

[7] Erhart M(2009)Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis Br J Psychiatry 194 204-211

[8] Ravens-Sieberer U(2001)Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Child Adolesc Psychiatry 40 1352-1355

[9] Froehlich TE(2011)ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents Pediatrics 128 1007-1022

[10] Lanphear BP(2011)Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence Eur Child Adolesc Psychiatry 20 S235-S242